INTRALESIONAL LOW DOSE METHYLPREDNISOLONE FOR THE TREATMENT OF ACTIVE PHASE PEYRONIE’S DISEASE: A SINGLE CENTER, PRELIMINARY PROSPECTIVE NON-RANDOMISED STUDY